tetanus toxoid vaccine / Serum Institute of India - LARVOL DELTA

Phase III Study on Rotavirus Vaccine to Evaluate Lot-to-lot Consistency and Interference With Routine UIP Immunization (clinicaltrials.gov) - P3; N=1500; Recruiting; Sponsor: Serum Institute of India Limited; Not yet recruiting ➔ Recruiting

Enrollment open • Biosimilar

Challenges and Opportunities While Developing a Group A Meningococcal Conjugate Vaccine Within a Product Development Partnership: A Manufacturer's Perspective From the Serum Institute of India. (PubMed) - Clin Infect Dis - "The project proved to be a sound investment for SIIL and is a concrete example of the potential for PDPs to provide needed products for resource-poor countries."

Journal • Biosimilar • Immunology • Inflammation